Effects of antiviral medications on herpetic epithelial keratitis in mice.

about

Effects of antiviral medications on herpetic epithelial keratitis in mice.

Item

http://www.wikidata.org/entity/Q41468795

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Effects of antiviral medications on herpetic epithelial keratitis in mice.

@en

type

Item

label

Effects of antiviral medications on herpetic epithelial keratitis in mice.

@en

prefLabel

Effects of antiviral medications on herpetic epithelial keratitis in mice.

@en

P1476

Effects of antiviral medications on herpetic epithelial keratitis in mice.

@en

P2093

Masahiko Fukuda

http://www.w3.org/2001/XMLSchema#string

Shiro Higaki

http://www.w3.org/2001/XMLSchema#string

Shohei Komoto

http://www.w3.org/2001/XMLSchema#string

Yoshikazu Shimomura

http://www.w3.org/2001/XMLSchema#string

P2860

Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]

Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits

Human herpesvirus latency.

Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Quantitative analysis of polymerase chain reaction products by dot blot.

Suppression of herpes simplex virus 1 reactivation in a mouse eye model by cyclooxygenase inhibitor, heat shock protein inhibitor, and adenosine monophosphate.

Gene expression profiling in the HSV-1 latently infected mouse trigeminal ganglia following hyperthermic stress.

Review of research leading to new anti-herpesvirus agents in clinical development: valaciclovir hydrochloride (256U, the L-valyl ester of acyclovir) and 882C, a specific agent for varicella zoster virus.

Activity of penciclovir in antiviral assays against herpes simplex virus.

Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo.

P2888

s10384-015-0375-3

P304

194-200

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10384-015-0375-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272844594

http://www.w3.org/2001/XMLSchema#string

P698

25707352

http://www.w3.org/2001/XMLSchema#string